Alan Irvine is a consultant dermatologist at Children’s Health Ireland and St James’s Hospital and Professor of Dermatology at Trinity College, both in Dublin, Ireland. He gained his MB, MD, and DSc qualifications from Queen’s University Belfast in Ireland. He completed his training in Dermatology and Genetics at Queen’s University Belfast and Great Ormond Street Hospital in London, UK.
Professor Irvine’s main areas of research are epithelial genetics, characterization of the skin barrier, disease mechanisms, and advanced therapy of atopic dermatitis, and therapeutic repurposing in rare and orphan diseases. In collaboration with Irwin McLean, he discovered common filaggrin mutations causing skin barrier dysfunction that led to a focus on the importance of the epithelial barrier in the pathogenesis of atopic and allergic diseases, which affect over 2 billion people. He has 25 years’ experience of design, conduct, and analysis of industry- and investigator-led clinical trials for common and orphan diseases.
Professor Irvine is an editorial board member of the journal Allergy, a section editor of The Journal of Infectious Diseases, and a reviewer in more than 30 other journals. He has authored or co-authored more than 300 peer-reviewed papers and has been the recipient of the Paul Gerson Unna Prize (2007) and the Times Higher Education Research Project of the Year Award (2006).
CP-307621 - Date of preparation: March 2022